Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability

被引:42
作者
Linton, David [1 ,2 ]
Barr, Alasdair M. [1 ,2 ]
Honer, William G. [1 ,3 ]
Procyshyn, Ric M. [1 ,3 ]
机构
[1] BC Mental Hlth & Addict Res Inst, Vancouver, BC V5Z 4H4, Canada
[2] Univ British Columbia, Biomed Res Ctr, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada
基金
加拿大健康研究院;
关键词
Antipsychotic agents; Central nervous system stimulants; Combination therapy; Guidelines; Attention-deficit/hyperactivity disorder; ADHD; Disruptive behavior disorders; DBD; Oppositional defiant disorder; ODD; Conduct disorder; CD; Children; Adolescents; Psychiatry; AGGRESSIVE YOUTH TRAAY; 2ND-GENERATION ANTIPSYCHOTICS; TREATMENT RECOMMENDATIONS; NATIONAL TRENDS; DOUBLE-BLIND; WEIGHT-GAIN; CHILDREN; ADOLESCENTS; RISPERIDONE; METHYLPHENIDATE;
D O I
10.1007/s11920-013-0355-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This systematic review examines treatment guidelines, efficacy/effectiveness, and tolerability regarding the use of antipsychotics concurrently with psychostimulants in treating aggression and hyperactivity in children and adolescents. Articles examining the concurrent use of antipsychotics and psychostimulants to treat comorbid attention deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs) were identified and their results were summarized and critically analyzed. Antipsychotic and stimulant combination therapy is recommended by some guidelines, but only as a third-line treatment following stimulant monotherapy and stimulants combined with behavioral interventions to treat aggression in patients with ADHD. Some studies suggest efficacy/effectiveness for an antipsychotic and stimulant combination in the treatment of aggression and hyperactivity in children and adolescents. However, the data do not clearly demonstrate superiority compared to antipsychotic or psychostimulant monotherapy. Most studies were performed over short time periods, several lacked blinding, few studies used any placebo control, and no comparisons were made with behavioral interventions. There are concerns about the tolerability of combination therapy, but data do not suggest significantly worse adverse effects for combination compared to either antipsychotic or stimulant monotherapy. Conversely, and contrary to speculation, use of a stimulant does not significantly reduce metabolic effects of antipsychotics. Combination treatment with antipsychotics and psychostimulants is used frequently, and increasingly more often. Few studies have directly examined this combination for the treatment of ADHD and DBDs. Further studies are necessary to confirm the efficacy and tolerability of the concurrent use of antipsychotics and psychostimulants in children and adolescents.
引用
收藏
页数:11
相关论文
共 46 条
[31]   Lack of Effect of Stimulant Combination with Second-Generation Antipsychotics on Weight Gain, Metabolic Changes, Prolactin Levels, and Sedation in Youth with Clinically Relevant Aggression or Oppositionality [J].
Penzner, Julie B. ;
Dudas, Melissa ;
Saito, Ema ;
Olshanskiy, Vladimir ;
Parikh, Umesh H. ;
Kapoor, Sandeep ;
Chekuri, Raja ;
Gadaleta, Dominick ;
Avedon, Jennifer ;
Sheridan, Eva M. ;
Randell, Jane ;
Malhotra, Anil K. ;
Kane, John M. ;
Correll, Christoph U. .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) :563-573
[32]   The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder [J].
Pliszka, Steven R. ;
Crismon, M. Lynn ;
Hughes, Carroll W. ;
Conners, C. Keith ;
Emslie, Graham J. ;
Jensen, Peter S. ;
McCracken, James T. ;
Swanson, James M. ;
Lopez, Molly .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (06) :642-657
[33]   The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005-2009 [J].
Pringsheim, Tamara ;
Lam, Darren ;
Patten, Scott B. .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (06) :537-543
[34]  
Procyshyn RM, 2007, J PSYCHIATR NEUROSCI, V32, P331
[35]   Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients [J].
Procyshyn, Ric M. ;
Honer, William G. ;
Wu, Tony K. Y. ;
Ko, Rebecca W. Y. ;
McIsaac, Sean A. ;
Young, Allan H. ;
Johnson, Joy L. ;
Barr, Alasdair M. .
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (05) :566-573
[36]   Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom [J].
Rani, Fariz ;
Murray, Macey L. ;
Byrne, Patrick J. ;
Wong, Ian C. K. .
PEDIATRICS, 2008, 121 (05) :1002-1009
[37]   Treatment of Maladaptive Aggression in Youth: CERT Guidelines II. Treatments and Ongoing Management [J].
Rosato, Nancy Scotto ;
Correll, Christoph U. ;
Pappadopulos, Elizabeth ;
Chait, Alanna ;
Crystal, Stephen ;
Jensen, Peter S. .
PEDIATRICS, 2012, 129 (06) :E1577-E1586
[38]   A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents [J].
Saito, E ;
Correll, CU ;
Gallelli, K ;
McMeniman, M ;
Parikh, UH ;
Malhotra, AK ;
Kafantaris, V .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (03) :350-358
[39]   Treatment recommendations for the use of Antipsychotics for aggressive youth (TRAAY). Part I: A review [J].
Schur, SB ;
Sikich, L ;
Findling, RL ;
Malone, RP ;
Crismon, ML ;
Derivan, A ;
MacIntyre, JC ;
Pappadopulos, E ;
Greenhill, L ;
Schooler, N ;
Van Orden, K ;
Jensen, PS .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (02) :132-144
[40]   Anti-hyperactivity medication: methylphenidate and amphetamine [J].
Seeman, P ;
Madras, BK .
MOLECULAR PSYCHIATRY, 1998, 3 (05) :386-396